GeniPhys

About GeniPhys

GeniPhys is pioneering the development and commercialization of its patented Collymer technology, a first-of-its-kind polymerizable scaffold-forming collagen. This technology supports the custom design and fabrication of collagen materials aimed at accelerating and improving tissue restoration and regeneration. GeniPhys serves clients in the healthcare sector, including both human and animal health markets. The company's business model revolves around the development and sale of its proprietary collagen scaffolds, which are designed to provide a long-lasting, mechanically stable natural scaffold that supports new tissue formation without triggering an inflammatory response. Although Collymer is still an investigational device and has not yet been cleared by the FDA, its broad customization capabilities and paradigm-shifting tissue response differentiate it from other options currently available. GeniPhys generates revenue through the sale of its collagen scaffolds and related products, targeting healthcare providers, research institutions, and potentially veterinary practices. The company operates with a mission grounded in compassion, integrity, and respect, aiming to positively impact health outcomes through innovative tissue restoration and regeneration therapies.